
Social Impact Award Türkiye — National Public Voting Winner
Selected as a finalist and national public voting winner in the Impact Hub × Anadolu Efes program.
Innorare brings together rare disease communities, researchers, healthcare professionals, entrepreneurs and institutions to develop accessible, sustainable and meaningful solutions.

Rare diseases are not only clinical challenges. They create social, psychological, economic and technological needs that today's health systems are not designed to meet.
Listen. Connect. Develop. A simple methodology for a complex ecosystem.
We begin with lived experience, real needs and stakeholder insight — not assumptions.
We bring together communities, science, healthcare, entrepreneurship and institutions.
We turn knowledge into research, technologies, projects and sustainable collaborations.
Applied research and product development around unmet needs shared across many rare conditions.
Learn moreBuilding bridges between patient communities, clinicians, students, researchers and institutions.
Learn moreWorking with global rare disease programs, accelerators and academic partners.
Learn moreAn investigational medical-device project developing an automated dual-phase disinfection approach for clean intermittent catheter (CIC) users. Currently in research, validation and preclinical development.
A pilot-stage, privacy-first community and digital health initiative designed to connect rare disease communities, knowledge and relevant stakeholders — without ever replacing medical care.
Rare challenges touch many lives at once. Innorare works at the intersection of these communities.
A short selection of programs, events and recognitions from Innorare's journey.

Selected as a finalist and national public voting winner in the Impact Hub × Anadolu Efes program.

A two-day hackathon focused on ALS, bringing students, clinicians and engineers together around real needs.
Recather awarded TÜBİTAK BİGG 1512 support; Demo Day completed at Acıbadem TEKMER, Phase 2 preclinical work initiated.
Recather secured validation-phase financial support at the BRIGHT Demo Day for cleanroom experiments, validation and preclinical work.

200+ participants and 23 organizations gathered at Acıbadem University for a national rare disease summit.
A partial view of organizations we have collaborated with across research, community and innovation programs.
Let's bring together knowledge, experience and technology to create meaningful health impact.